Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV-Reference-Cited by-同舟云学术

Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV

Published:2012-03-05 Issue:6 Volume:67 Page:1449-1452
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Dominguez S.,Ghosn J.,Cassard B.,Melica G.,Poizot-Martin I.,Solas C.,Lascaux A.-S.,Bouvier-Alias M.,Katlama C.,Levy Y.,Peytavin G.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/67/6/1449/2017573/dks045.pdf

Reference10 articles.

1. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection

2. Ribavirin Plasma Concentration Predicts Sustained Virological Response to Peginterferon Alfa 2a Plus Ribavirin in Previously Treated HCV-HIV–Coinfected Patients

3. The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon

4. Plasma/erythrocyte ribavirin ×100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#;Intensive Care Medicine;2020-05-07

2. Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients;World Journal of Hepatology;2018-11-27

3. Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics;Tropical Medicine & International Health;2018-01-10

4. Lower Ribavirin Plasma Concentrations in HCV/HIV–Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage;Therapeutic Drug Monitoring;2015-12

5. SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir;Journal of Antimicrobial Chemotherapy;2015-01-11